The weight-loss drug market just got more crowded — and a lot less painful. The FDA on Monday approved a daily pill version of Novo Nordisk’s Wegovy, making it the first oral GLP-1 obesity treatment ...
Americans seeking to lose weight now have a new option – taking Wegovy as a daily pill, rather than a weekly injection.
Americans can now buy the starter dose of the widely used weight loss drug Wegovy in pill form. The announcement was made on Monday by drugmaker Novo Nordisk. Higher strengths of the medication are ...
The US Food and Drug Administration has approved Novo Nordisk’s once-daily weight-loss pill, making it the first oral glucagon-like peptide 1 (GLP-1) product available for weight management. The pill, ...